NFKB1 and cancer: EGCG has shown multiple effects on the major signaling pathways governing carcinogenesis and cancer progression, including MAP kinase (MAPK), phosphatidylinositol-3 kinase (PI3K), nuclear factor κB (NFkB), and reducing the increased levels of phosphorylation of ERK1/2 and Jak/STAT3 [14].